Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Cabozantinib + Nivolumab for Advanced Skin and Head & Neck Cancers
Recruiting1 awardPhase 2
Saint Louis Park, Minnesota
This trialstudies combining two drugs to treat melanoma and head/neck cancer that has spread to other parts of the body. It also looks at biomarkers in tumors to see how well treatment works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service